Aboutlawsuits.com reports increasing likelihood that an FDA advisory panel will recommend that an Avandia recall be issued next month, as two new studies (provide further evidence that GlaxoSmithKline’s diabetes drug increases the risk of heart attack and life-threatening injuries.
The article continues that an independent panel of expert advisers to the FDA is scheduled to meet on July 13 and 14 to make recommendations about what steps the regulatory agency should take to protect consumers. While the FDA is not required to follow the advisory committee’s advice, the release of the two studies on Monday, and the advisory panel’s anticipated decision, is expected to bring considerable pressure on FDA to recall Avandia from the market.
We handle Avandia cases and are still accepting new cases. If you or a family member took Avandia and you believe may have suffered a heart attack or death, please contact the head of the pharmaceutical practice area, Todd Hageman.